DK2202307T3 - Fremgangsmåde til fremstiling af et antistof - Google Patents

Fremgangsmåde til fremstiling af et antistof

Info

Publication number: DK2202307T3
Authority: DK; Denmark
Prior art keywords: antibody; producing
Prior art date: 2007-10-15

Application number

DK08838661.0T

Other languages

English (en)

Other versions

DK2202307T4 (da

Inventor

Yoshiki Yamada

Tatsuya Kiyasu

Kazuyuki Tabata

Akihiro Kuzumaki

Mai Yamashiro

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-15

Filing date

2008-10-14

Publication date

2014-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2202307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-14 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

2014-09-15 Application granted granted Critical

2014-09-15 Publication of DK2202307T3 publication Critical patent/DK2202307T3/da

2021-10-04 Publication of DK2202307T4 publication Critical patent/DK2202307T4/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

DK08838661.0T 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof DK2202307T4 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2007267384		2007-10-15
JP2008103308		2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja)	2007-10-15	2008-10-14	抗体の製造方法

Publications (2)

Publication Number	Publication Date
DK2202307T3 true DK2202307T3 (da)	2014-09-15
DK2202307T4 DK2202307T4 (da)	2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08838661.0T DK2202307T4 (da)	2007-10-15	2008-10-14	Fremgangsmåde til fremstiling af et antistof

Country Status (17)

Country	Link
US (2)	US9683027B2 (da)
EP (1)	EP2202307B2 (da)
JP (4)	JP4976502B2 (da)
KR (1)	KR101558009B1 (da)
CN (3)	CN103540632A (da)
AU (1)	AU2008312937B2 (da)
BR (1)	BRPI0818674B1 (da)
CA (1)	CA2701338C (da)
DK (1)	DK2202307T4 (da)
ES (1)	ES2499391T5 (da)
IL (2)	IL205051A (da)
MX (1)	MX2010004007A (da)
PL (1)	PL2202307T5 (da)
SG (1)	SG185302A1 (da)
SI (1)	SI2202307T2 (da)
TW (1)	TWI463010B (da)
WO (1)	WO2009051108A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009051108A1 (ja) *	2007-10-15	2009-04-23	Chugai Seiyaku Kabushiki Kaisha	抗体の製造方法
SI2493922T1 (sl)	2009-10-26	2017-06-30	F. Hoffmann-La Roche Ag	Postopek za proizvodnjo glikoziliranega imunoglobulina
SG191371A1 (en) *	2010-12-28	2013-08-30	Chugai Pharmaceutical Co Ltd	Animal cell culturing method
CN105246510A (zh) *	2013-03-15	2016-01-13	豪夫迈·罗氏有限公司	细胞培养培养基和抗体生产方法
MX363403B (es)	2013-07-04	2019-03-22	Hoffmann La Roche	Inmumoensayo con interferencia suprimida para la deteccion de anticuerpos anti-farmacos en muestras de suero.
WO2018002036A1 (en)	2016-06-28	2018-01-04	Zaklady Farmaceutyczne Polpharma Sa	Recombinant production of monoclonal antibodies
US20190374639A1 (en)	2016-11-21	2019-12-12	Polpharma Biologics S.A.	Aqueous pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
JPS6459878A (en)	1987-08-31	1989-03-07	Matsushita Electric Ind Co Ltd	Semiconductor laser protective circuit
WO1992020791A1 (en)	1990-07-10	1992-11-26	Cambridge Antibody Technology Limited	Methods for producing members of specific binding pairs
GB9015198D0 (en)	1990-07-10	1990-08-29	Brien Caroline J O	Binding substance
WO1993012227A1 (en)	1991-12-17	1993-06-24	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
DK0814159T3 (da)	1990-08-29	2005-10-24	Genpharm Int	Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
EP0548267A4 (en) †	1990-09-04	1994-11-23	Salk Inst Biotech Ind	Production of insulin-like growth factor-1 in methylotrophic yeast cells
TW205553B (da)	1991-04-25	1993-05-11	Chugai Pharmaceutical Co Ltd
EP0605522B1 (en)	1991-09-23	1999-06-23	Medical Research Council	Methods for the production of humanized antibodies
ES2227512T3 (es)	1991-12-02	2005-04-01	Medical Research Council	Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
WO1993019172A1 (en)	1992-03-24	1993-09-30	Cambridge Antibody Technology Limited	Methods for producing members of specific binding pairs
ES2301158T3 (es)	1992-07-24	2008-06-16	Amgen Fremont Inc.	Produccion de anticuerpos xenogenicos.
AU6819494A (en)	1993-04-26	1994-11-21	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en)	1993-06-30	1993-08-11	Medical Res Council	Chemisynthetic libraries
CA2177367A1 (en)	1993-12-03	1995-06-08	Andrew David Griffiths	Recombinant binding proteins and peptides
EP0770628B9 (en)	1994-07-13	2007-02-28	Chugai Seiyaku Kabushiki Kaisha	Reconstituted human antibody against human interleukin-8
US5561053A (en)	1994-08-05	1996-10-01	Genentech, Inc.	Method for selecting high-expressing host cells
CA2761116A1 (en)	1995-04-27	1996-10-31	Amgen Fremont Inc.	Human antibodies derived from immunized xenomice
CA2219486A1 (en)	1995-04-28	1996-10-31	Abgenix, Inc.	Human antibodies derived from immunized xenomice
EP0985033A4 (en) *	1997-04-04	2005-07-13	Biosite Inc	POLYVALENT AND POLYCLONAL LIBRARIES
CA2288600C (en)	1997-05-02	2010-06-01	Genentech, Inc.	A method for making multispecific antibodies having heteromultimeric and common components
US20020062010A1 (en)	1997-05-02	2002-05-23	Genentech, Inc.	Method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) *	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
US20030003097A1 (en) †	2001-04-02	2003-01-02	Idec Pharmaceutical Corporation	Recombinant antibodies coexpressed with GnTIII
US6605176B2 (en)	2001-07-13	2003-08-12	Taiwan Semiconductor Manufacturing Co., Ltd.	Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) *	2001-11-16	2003-08-21	Idec Pharmaceuticals Corporation	Polycistronic expression of antibodies
NZ533056A (en)	2001-11-16	2007-12-21	Biogen Idec Inc	Polycistronic expression of antibodies
EP1652925B1 (en)	2003-07-15	2010-12-08	Chugai Seiyaku Kabushiki Kaisha	IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION
WO2005089285A2 (en) *	2004-03-15	2005-09-29	Biogen Idec Ma Inc.	Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
EP2216046B1 (en)	2004-07-09	2014-03-12	Chugai Seiyaku Kabushiki Kaisha	Anti-glypican 3 antibody
GB0425534D0 (en)	2004-11-19	2004-12-22	Celltech R&D Ltd	Process for obtaining antibodies
SG164383A1 (en) †	2005-07-21	2010-09-29	Abbott Lab	Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
WO2009051108A1 (ja) *	2007-10-15	2009-04-23	Chugai Seiyaku Kabushiki Kaisha	抗体の製造方法

2008
- 2008-10-14 WO PCT/JP2008/068588 patent/WO2009051108A1/ja active Application Filing
- 2008-10-14 MX MX2010004007A patent/MX2010004007A/es active IP Right Grant
- 2008-10-14 BR BRPI0818674-0A patent/BRPI0818674B1/pt active IP Right Grant
- 2008-10-14 SG SG2012076485A patent/SG185302A1/en unknown
- 2008-10-14 ES ES08838661T patent/ES2499391T5/es active Active
- 2008-10-14 AU AU2008312937A patent/AU2008312937B2/en active Active
- 2008-10-14 CN CN201310401442.2A patent/CN103540632A/zh active Pending
- 2008-10-14 KR KR1020107008087A patent/KR101558009B1/ko active IP Right Grant
- 2008-10-14 SI SI200831306T patent/SI2202307T2/sl unknown
- 2008-10-14 PL PL08838661T patent/PL2202307T5/pl unknown
- 2008-10-14 US US12/734,094 patent/US9683027B2/en active Active
- 2008-10-14 CA CA2701338A patent/CA2701338C/en active Active
- 2008-10-14 JP JP2009538093A patent/JP4976502B2/ja active Active
- 2008-10-14 EP EP08838661.0A patent/EP2202307B2/en active Active
- 2008-10-14 CN CN200880106430A patent/CN101802192A/zh active Pending
- 2008-10-14 CN CN201610656433.1A patent/CN106244651A/zh active Pending
- 2008-10-14 DK DK08838661.0T patent/DK2202307T4/da active
- 2008-10-15 TW TW097139552A patent/TWI463010B/zh active
2010
- 2010-04-13 IL IL205051A patent/IL205051A/en active IP Right Grant
2012
- 2012-04-12 JP JP2012090908A patent/JP5788830B2/ja active Active
2015
- 2015-06-05 JP JP2015114464A patent/JP6092304B2/ja active Active
- 2015-07-23 IL IL240122A patent/IL240122B/en active IP Right Grant
2017
- 2017-02-08 JP JP2017020965A patent/JP6506786B2/ja active Active
- 2017-05-08 US US15/589,000 patent/US11136375B2/en active Active

Also Published As

Publication number	Publication date
DK2202307T4 (da)	2021-10-04
KR101558009B1 (ko)	2015-10-19
JP4976502B2 (ja)	2012-07-18
CN103540632A (zh)	2014-01-29
TW200934867A (en)	2009-08-16
EP2202307A4 (en)	2012-01-25
IL240122A0 (en)	2015-09-24
PL2202307T3 (pl)	2015-02-27
CN101802192A (zh)	2010-08-11
CN106244651A (zh)	2016-12-21
JP5788830B2 (ja)	2015-10-07
JPWO2009051108A1 (ja)	2011-03-03
JP2017079794A (ja)	2017-05-18
US11136375B2 (en)	2021-10-05
JP2012143246A (ja)	2012-08-02
WO2009051108A1 (ja)	2009-04-23
CA2701338A1 (en)	2009-04-23
BRPI0818674B1 (pt)	2023-01-17
US20210300996A1 (en)	2021-09-30
JP2015198663A (ja)	2015-11-12
IL205051A0 (en)	2010-11-30
US9683027B2 (en)	2017-06-20
EP2202307A1 (en)	2010-06-30
KR20100074184A (ko)	2010-07-01
TWI463010B (zh)	2014-12-01
JP6506786B2 (ja)	2019-04-24
BRPI0818674A2 (pt)	2014-10-14
IL205051A (en)	2015-09-24
PL2202307T5 (pl)	2021-10-04
CA2701338C (en)	2018-09-18
ES2499391T3 (es)	2014-09-29
EP2202307B2 (en)	2021-07-14
ES2499391T5 (es)	2021-12-22
IL240122B (en)	2019-02-28
US20100291627A1 (en)	2010-11-18
EP2202307B1 (en)	2014-08-20
US20170275351A1 (en)	2017-09-28
JP6092304B2 (ja)	2017-03-08
SI2202307T2 (sl)	2021-11-30
AU2008312937B2 (en)	2015-01-22
MX2010004007A (es)	2010-06-15
SI2202307T1 (sl)	2014-11-28
SG185302A1 (en)	2012-11-29
AU2008312937A1 (en)	2009-04-23

Publication	Publication Date	Title
DK2054711T3 (da)	2020-12-14	Fremgangsmåde til fremstilling af mikroarrays
DK2044002T3 (da)	2014-07-07	Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider
DK3730045T3 (da)	2022-04-04	Fremgangsmåde til indføring af en analytsensor
DK2350128T3 (da)	2014-12-01	Fremgangsmåder til fremstilling af antistoffer fra plasmaceller
BRPI0814359A2 (pt)	2015-08-11	Método
BRPI0817226A2 (pt)	2015-06-16	Método
BRPI0817726A2 (pt)	2015-03-31	Método
BRPI0907532A2 (pt)	2015-07-28	Anticorpos anti-c5ar humanizados
DK3714788T3 (da)	2023-04-17	Fremgangsmåde til fremstilling af forbedrede analytsensorer
DK2451839T3 (da)	2020-07-13	Fremgangsmåde til produktion af variable domæner
DK2126801T3 (da)	2013-06-24	Fremgangsmåde til udvælgelse af information
DK2358661T3 (da)	2014-06-30	Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2029567T3 (da)	2010-11-29	Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
DK1844662T3 (da)	2019-08-19	Metode til belægning af objekter
DK2531526T3 (da)	2017-11-13	Fremgangsmåde til opnåelse af antistoffer
DK3106874T3 (da)	2020-06-02	Fremgangsmåde til detektering af cancer
DK2061746T3 (da)	2013-11-25	Fremgangsmåde til fremstilling af diestere
DK2076330T3 (da)	2019-07-29	Fremgangsmåde til fremstilling af katalysatorer
FI20075505A (fi)	2009-01-05	Menetelmä silmälasien valmistamiseksi
DK2367783T3 (da)	2013-04-08	Fremgangsmåde til fremstilling af et isocyanat
DK2019118T3 (da)	2013-02-04	Fremgangsmåde til syntetisering af thymosiner
DK1976960T3 (da)	2009-11-16	Fremgangsmåde til fremstilling af biodiesel
DK2160225T3 (da)	2013-09-02	Fremgangsmåde til fremstilling af krystaller
DK2021309T3 (da)	2014-07-21	Fremgangsmåde til fremstilling af methanol
FI20065363A0 (fi)	2006-05-30	Erotusmenetelmä